Blog

Antibiotics and Probiotics

17 min readBy Entegro Health

Antibiotics are one of the best things medicine ever invented, and they are rough on your gut. Both of those are true, and the second one is worth planning for.

A woman at home holding a single white tablet in one hand and a glass of water in the other

Photo: JESHOOTS.com/ https://www.pexels.com

Antibiotics are not the villain here. They turned diseases that used to kill people into things you clear up in a week. If your doctor has prescribed a course, take it and finish it.

What is also true is that most antibiotics can’t tell your infection apart from the bacteria you were rather enjoying having. That is where probiotics come into the conversation — strong evidence in one specific place, and thin evidence almost everywhere else.

This article is about research, not treatment. Flourish is a dietary supplement, not a medicine, and nothing here treats or prevents any infection. Never start, stop or change a prescribed antibiotic based on anything you read here. If you are unwell, or your symptoms get worse during a course, call your doctor.

What antibiotics actually do to your gut

An older woman reading the leaflet from her prescription while a pharmacist stands beside her

Photo: cottonbro studio/ https://www.pexels.com

Most antibiotics work on bacteria in general rather than picking out the ones making you ill. How much collateral damage that does depends enormously on the drug. A narrow-spectrum antibiotic for a straightforward infection is a scalpel. A broad-spectrum one is closer to a leaf blower. This is exactly why doctors reach for the narrowest thing that will work.

So how long does it take to bounce back?

One study answers this rather well. Twelve healthy men were given a four-day course of three last-resort antibiotics — meropenem, gentamicin and vancomycin, which is about as harsh as it gets — and then had their gut bacteria tracked for six months.1

What happened

  • Straight after: blooms of less welcome organisms, and a drop in Bifidobacterium and butyrate producers.
  • About six weeks later: the gut microbiota had recovered to near-baseline composition.
  • Six months later: nine species that had been present in every participant beforehand were still undetectable in most of them.

The researchers described healthy adults’ gut microbiota as resilient to a short course — a mild but long-lasting imprint rather than devastation.

The side effects worth knowing about

Diarrhea, abdominal discomfort, nausea, digestive upset and vomiting are the common ones. Less commonly: skin rashes, dizziness, and rarely a severe allergic reaction. Not everyone gets any of them.

Antibiotic resistance belongs in a different category, and it is worth separating out properly. Resistance isn’t a side effect you experience — it is something that happens to the bacteria. The CDC describes it as germs developing “the ability to defeat the drugs designed to kill them.”2 It is a shared, public problem rather than a personal one, and the way to limit it is to take antibiotics only when they are genuinely needed, and exactly as prescribed.3

The one thing probiotics are genuinely good at here

Antibiotic-associated diarrhea. That is the claim with real evidence behind it, and the numbers are worth having in front of you.

The best-known analysis is a 2012 systematic review in JAMA. It included 82 randomized trials and pooled 63 of them, covering 11,811 people. Taking a probiotic alongside antibiotics was associated with a 42% lower relative risk of antibiotic-associated diarrhea — which in absolute terms is about 7 fewer cases per 100 people, or one case avoided for every 13 people who take one.4

A 2021 review of 42 randomized trials in 11,305 adults found much the same shape: a 37% lower relative risk, at moderate certainty on the GRADE scale.5 In children, a Cochrane review of 33 studies found the incidence fell from 19% on placebo to 8% on a probiotic, also at moderate certainty.6 European pediatric guidance goes further and names the two organisms it will actually recommend — Lactobacillus rhamnosus GG and Saccharomyces boulardii — adding that for other strains and combinations “sufficient evidence is still lacking.”24

Three independent analyses, three consistent answers — and all three land in the same modest place.

Two caveats that decide whether this applies to you

Only some probiotics worked. In the words of the 2021 review, “only certain species, mainly of the Lactobacillus and Bifidobacteria genera, were found to be effective.” Not any variety, not any product.5 Higher doses also outperformed lower ones, in both that review and the pediatric Cochrane one.

Benefit depended on your starting risk. Studies in people at low baseline risk of diarrhea showed no difference at all.5 If you are an otherwise healthy adult on a short outpatient course, you are probably in that group — which is the group where no benefit has been shown.

It is worth understanding why that first caveat exists, because it governs how to read every number on this page. Probiotic effects are strain-specific, and that is not a technicality. A systematic review of the question found that within a single species, some strains prevented antibiotic-associated diarrhea in adults and others simply did not.21 The international consensus definition makes the same point: strain designation matters, because different strains of the same species can have different effects.22 So the results above belong to the particular strains that were tested, at the doses they were tested at. They are not a property of probiotics in general.

And on C. difficile

C. difficile is the serious end of antibiotic-associated diarrhea. The current Cochrane review pooled 47 studies and 15,260 people, and found probiotics associated with a drop from 3.2% to 1.6% — a 1.6 percentage point absolute reduction, roughly one case prevented per 65 people treated. Cochrane rates that low-certainty evidence.7

The same review found no difference in length of hospital stay, at moderate certainty.7 And it noted probiotic-company affiliations or funding in 28 of the 47 studies.

The two major gastroenterology societies land in different places on it. The American Gastroenterological Association gives conditional, low-certainty support for specific named strain combinations in patients on antibiotics.8 The American College of Gastroenterology recommends against probiotics for preventing C. difficile infection.9 On current evidence, this is an unsettled question.

Helping antibiotics do their job

H. pylori is a bacterium that settles in the stomach lining and is a leading cause of ulcers; clearing it takes a combination of antibiotics.25 A 2020 meta-analysis of 40 trials in 5,792 patients found that adding a probiotic to standard H. pylori treatment raised the eradication rate by about 10 percentage points, and reduced treatment side effects.10 A larger network meta-analysis of 140 studies found a similar direction — and also found that combining multiple probiotic strains did not work better than using one.11 Neither review formally graded the certainty of its evidence.

The thing everyone gets backwards

A quiet kitchen table set with seeded bread, fresh quinces and a stovetop coffee pot

Photo: hello aesthe/ https://www.pexels.com

The familiar version goes like this: antibiotics wipe out your good bacteria, so take a probiotic to replace them. It is intuitive, and it is not what the research shows.

A systematic review of randomized trials found no measurable effect of probiotic supplementation on the gut microbiota composition of healthy adults — not on diversity, not on richness, not on evenness.12 Probiotics pass through. They largely don’t move in.

And it may go further than that

A 2018 study in Cell used endoscopic biopsies rather than stool samples to watch people’s gut communities rebuild after a course of antibiotics. Compared with recovering unaided, an 11-strain probiotic produced a markedly delayed and persistently incomplete return of the participants’ own native bacteria.13

A companion study found the same probiotics survived the journey perfectly well but ran into individual resistance to actually settling in — and, tellingly, that finding them in stool told you nothing about whether they had colonized the gut wall.14

So the two things are separate, and only one of them is well supported:

Two different questions

  • Will a probiotic reduce your chance of diarrhea while you are on antibiotics? Reasonably well evidenced, with the caveats above about strain and baseline risk.
  • Will it rebuild your microbiome afterwards? Not shown — and in the most careful study of the question, the probiotic group recovered more slowly than the group that took nothing.

Reducing loose stools during a course and restoring your gut community afterwards are two different outcomes, and the evidence for them is not the same.

For the fuller picture on what your microbiome does and how it recovers, that is its own article.

If you are going to take one, when?

A plain glass of water on a bare wooden table, lit by a band of morning sunlight

Photo: Elena Golovchenko/ https://www.pexels.com

The useful answer here is about days rather than hours.

A meta-regression of 19 trials in 6,261 hospitalized adults found that probiotics worked better the sooner they were started after the first antibiotic dose, with a measurable loss of benefit for each day of delay. Starting within two days of the antibiotic cut the risk substantially more than starting later.15 The reviewers rated the overall quality of that evidence as high.

The advice you see on every label — space your probiotic about two hours from your antibiotic — is a sensible precaution, though it has not been tested directly in a clinical trial. What has been tested, and what showed a real effect, is how many days you waited before starting.

Most trials continued the probiotic for the length of the antibiotic course and for a short while afterwards.

Who should check with a doctor first

Probiotics are not risk-free for everyone

A systematic review of published case reports found 93 patients with infections linked to probiotic use. Fungemia was the most common, and the risk factors identified included being over 60, having C. difficile colitis, and taking antibiotics.16

In one trial in patients with predicted severe acute pancreatitis, a probiotic preparation was associated with higher mortality than placebo, and the authors concluded it should not be given to that group at all.17

Talk to your doctor first if you are immunocompromised, seriously unwell or in hospital, have a central line, are recovering from major surgery, are pregnant or nursing, or are considering a probiotic for an infant or very young child. The FDA has not approved any probiotic product for use in infants of any age.18

One condition-specific note. If you have or suspect SIBO, raise it with your clinician before adding a probiotic. The ACG’s guideline states there is a lack of consistent data to support recommending specific probiotics for SIBO, and reports a controlled study in which probiotics themselves contributed to SIBO and D-lactic acidosis, with symptoms resolving when the probiotic was stopped.19 The trials that do exist are small and mostly open-label — one of the better-known ones enrolled forty patients with no blinding.20 More on this in our article on SIBO.

Where Flourish fits

A dose of Entegro Flourish being poured onto a spoon on a kitchen counter

Flourish is a living liquid probiotic, delivered in the liquid it was fermented in rather than freeze-dried into a capsule. Each tablespoon carries 11 live cultures from 5 genera — Lactobacillus, Bifidobacterium, Enterococcus, Bacillus and Saccharomyces — grown together as one culture on non-GMO sugarcane molasses or sweet sorghum, with every batch third-party tested.

On the liquid format: one laboratory study compared eight commercial probiotic products in simulated stomach conditions and found the liquid ones generally survived better than the freeze-dried ones, delivering viable counts at or above their label claims.23 That was a test tube rather than a person, Flourish was not among the eight, and surviving the stomach is not the same as settling in downstream.14 It is a promising format rather than a proven one.

What we’d claim for Flourish is digestive and microbiome support, taken consistently — which is why consistency is key. If you are on antibiotics and thinking about adding one, the sensible move is to ask the person who prescribed them.

Flourish is a dietary supplement made to support digestive and microbiome health. It is not a treatment for any infection or condition and is not a substitute for prescribed medication. Follow the dosage on the label. Check with your doctor before starting a new supplement, and with your pediatrician before giving one to a child.

Entegro Flourish being poured into a glass on a kitchen table beside a bowl of fresh fruit

Ready to try a living probiotic?

Eleven living cultures. One daily shot. For the whole family — grown-ups and older kids alike.

Shop Flourish Original  ·  Shop Flourish Junior  ·  When to take it

And since taking it regularly is the part that actually matters, that’s what Subscribe & Save is for: 5% off all Subscribe & Save orders, plus free shipping on subscriptions of 2+ Flourish.

A few questions we hear a lot

Should I take a probiotic with my antibiotics?

It might reduce your chance of diarrhea, and the evidence for that is reasonably good. Two things decide whether it applies to you: the strain, since only certain ones worked in the trials, and your baseline risk, since no benefit showed up in people at low risk of diarrhea to begin with.5 Ask whoever prescribed the antibiotic.

Do probiotics replace the good bacteria antibiotics kill?

That is the popular framing and it is not what the research shows. Probiotics have no measurable effect on the gut microbiota composition of healthy adults,12 and in the most careful study of post-antibiotic recovery, the probiotic group’s own native bacteria came back more slowly than in people who took nothing.13

How long until my gut recovers on its own?

After a four-day course of three powerful antibiotics, twelve healthy men were back to near-baseline composition in about six weeks — though nine species were still missing at six months.1 The researchers described healthy adults’ gut microbiota as resilient to a short course.

When should I start, and should I space the doses?

Start early. Trials showed a measurable loss of benefit for every day of delay, with the best results when the probiotic began within two days of the first antibiotic dose.15 Spacing each dose a couple of hours from the antibiotic is a reasonable precaution, but it has not been tested in a trial — the evidence is about days, not hours.

Can I stop my antibiotics early if I feel better?

No. Finish the course as prescribed, and talk to your doctor if something about it is bothering you.3

Is a multi-strain probiotic better than a single strain?

Not necessarily. The largest network meta-analysis in H. pylori treatment found that combined probiotics did not perform better than a single strain.11

Do these results apply to any probiotic I buy?

Not automatically. Probiotic effects are strain-specific, so a result belongs to the strain and dose that were tested rather than to probiotics as a category.21,22 If a particular result matters to you, look for the strain designation.

About this article

Written by: Kelsy Armstrong, Entegro Health | Originally published: January 2024

Important information

This article is for general education and isn’t a substitute for professional medical advice, diagnosis, or treatment. Probiotic effects are specific to the strain and to the outcome studied; evidence for one product does not transfer to another. Nothing here treats or prevents any infection, and nothing here is a reason to start, stop or change a prescribed medication. If you are unwell, please speak to a qualified health professional. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Sources

  1. Palleja, A., Mikkelsen, K. H., Forslund, S. K., et al. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3(11), 1255–1265 — 12 healthy men, 4-day meropenem/gentamicin/vancomycin course; near-baseline recovery within about 6 weeks, 9 common species still undetectable at 180 days. Source
  2. Centers for Disease Control and Prevention. Antimicrobial Resistance: Facts and Stats — “antimicrobial resistance happens when germs like bacteria and fungi develop the ability to defeat the drugs designed to kill them.” Source
  3. MedlinePlus, U.S. National Library of Medicine. Antibiotics — general patient information on what antibiotics treat and how to take them. Source
  4. Hempel, S., Newberry, S. J., Maher, A. R., et al. (2012). Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA, 307(18), 1959–1969 — 82 RCTs included, 63 pooled, 11,811 participants; RR 0.58 (95% CI 0.50–0.68), risk difference −0.07, NNT 13. The authors note substantial heterogeneity and that the evidence is insufficient to determine which probiotics work, at what dose, for whom. Source
  5. Goodman, C., Keating, G., Georgousopoulou, E., Hespe, C., & Levett, K. (2021). Probiotics for the prevention of antibiotic-associated diarrhoea: a systematic review and meta-analysis. BMJ Open, 11(8), e043054 — 42 studies, 11,305 adults; RR 0.63, GRADE moderate. “Only certain species, mainly of the lactobacillus and bifidobacteria genera, were found to be effective”; studies with a low baseline risk showed no difference. Source
  6. Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews, (4), CD004827 — 33 studies, 6,352 children; 8% vs 19% incidence, RR 0.45, moderate-certainty evidence; higher doses more effective than lower. Source
  7. Esmaeilinezhad, Z., Ghosh, N. R., Walsh, C. M., et al. (2025). Probiotics for the prevention of Clostridioides difficile-associated diarrhea in adults and children. Cochrane Database of Systematic Reviews — 47 studies, 15,260 participants; 1.6% vs 3.2%, RR 0.50, NNT 65, low-certainty evidence (downgraded from moderate); little to no difference in length of hospital stay (MD −0.07, moderate certainty); probiotic-company affiliation or funding noted in 28 studies. Source
  8. Su, G. L., Ko, C. W., Bercik, P., et al. (2020). AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology, 159(2), 697–705 — conditional, low-certainty support for specified strain combinations in patients on antibiotics; “no recommendation” for most other indications. Source
  9. Kelly, C. R., Fischer, M., Allegretti, J. R., et al. (2021). ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. American Journal of Gastroenterology, 116(6), 1124–1147 — recommends against probiotics for primary prevention of CDI in patients receiving antibiotics. Source
  10. Zhang, M., Zhang, C., Zhao, J., Zhang, H., Zhai, Q., & Chen, W. (2020). Meta-analysis of the efficacy of probiotic-supplemented therapy on the eradication of H. pylori and incidence of therapy-associated side effects. Microbial Pathogenesis, 147, 104403 — 40 articles, 5,792 patients; eradication improved by approximately 10% relative to control (OR 1.94), side effects reduced. No formal certainty grading. Source
  11. Wang, F., Feng, J., Chen, P., et al. (2017). Probiotics in Helicobacter pylori eradication therapy: systematic review and network meta-analysis. Clinics and Research in Hepatology and Gastroenterology, 41(4), 466–475 — 140 studies, 20,215 patients; eradication 84.1% with probiotics vs 70.5% control, and combined probiotics did not show better efficacy or tolerance than single use. Source
  12. Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016). Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Medicine, 8(1), 52 — 7 RCTs; no effects on α-diversity, richness or evenness in any included study versus placebo. Source
  13. Suez, J., Zmora, N., Zilberman-Schapira, G., et al. (2018). Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell, 174(6), 1406–1423.e16 — endoscopic mucosal sampling; probiotics induced “a markedly delayed and persistently incomplete indigenous stool/mucosal microbiome reconstitution” compared with spontaneous recovery. Source
  14. Zmora, N., Zilberman-Schapira, G., Suez, J., et al. (2018). Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell, 174(6), 1388–1405.e21 — probiotics remained viable through gastrointestinal passage but met person-specific mucosal colonization resistance, and colonization was “indistinguishable by probiotics presence in stool.” Source
  15. Shen, N. T., Maw, A., Tmanova, L. L., et al. (2017). Timely use of probiotics in hospitalized adults prevents Clostridium difficile infection: a systematic review with meta-regression analysis. Gastroenterology, 152(8), 1889–1900.e9 — 19 studies, 6,261 subjects; pooled RR 0.42; efficacy decreased for every day of delay; started within 2 days RR 0.32 vs later RR 0.70. Overall quality of evidence rated high. Source
  16. Costa, R. L., Moreira, J., Lorenzo, A., & Lamas, C. C. (2018). Infectious complications following probiotic ingestion: a potentially underestimated problem? A systematic review of reports and case series. BMC Complementary and Alternative Medicine, 18(1), 329 — 93 patients across 60 case reports and 7 case series; fungemia most common (37.6%); age over 60, C. difficile colitis and antibiotic use associated with mortality. Source
  17. Besselink, M. G., van Santvoort, H. C., Buskens, E., et al. (2008). Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet, 371(9613), 651–659 — 16% mortality in the probiotic group vs 6% on placebo (RR 2.53); the authors conclude probiotic prophylaxis should not be administered in this patient group. Source
  18. U.S. Food and Drug Administration (26 October 2023). FDA raises concerns about probiotic products sold for use in hospitalized preterm infants — “The FDA has not approved any probiotic product for use as a drug or biological product in infants of any age.” Source
  19. Pimentel, M., Saad, R. J., Long, M. D., & Rao, S. S. C. (2020). ACG clinical guideline: small intestinal bacterial overgrowth. American Journal of Gastroenterology, 115(2), 165–178 — “there is a lack of consistent data to support recommending specific probiotics in the treatment of SIBO,” and reports a controlled study in which probiotics may cause SIBO and D-lactic acidosis. Source
  20. García-Collinot, G., Madrigal-Santillán, E. O., Martínez-Bencomo, M. A., et al. (2020). Effectiveness of Saccharomyces boulardii and metronidazole for small intestinal bacterial overgrowth in systemic sclerosis. Digestive Diseases and Sciences, 65(4), 1134–1143 — an open, unblinded pilot trial in 40 patients. Source
  21. McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018). Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Frontiers in Medicine, 5, 124 — strain-specific efficacy for preventing adult antibiotic-associated diarrhea was clearly demonstrated within the Lactobacillus species, “while other Lactobacillus strains did not show efficacy.” Source
  22. Hill, C., Guarner, F., Reid, G., et al. (2014). Expert consensus document: the ISAPP consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology, 11(8), 506–514 — “the strain designation is important, as different strains of the same species may have different health effects.” Source
  23. Fredua-Agyeman, M., & Gaisford, S. (2015). Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry. Beneficial Microbes, 6(1), 141–151 — eight commercial products tested in vitro; liquid-based products tended to give superior survival results compared with the freeze-dried products tested. Source
  24. Szajewska, H., Canani, R. B., Guarino, A., et al.; ESPGHAN Working Group for Probiotics and Prebiotics (2016). Probiotics for the prevention of antibiotic-associated diarrhea in children. Journal of Pediatric Gastroenterology and Nutrition, 62(3), 495–506 — recommends Lactobacillus rhamnosus GG or Saccharomyces boulardii by name, and notes that for other strains or combinations “sufficient evidence is still lacking.” Source
  25. Mayo Clinic. Helicobacter pylori (H. pylori) infection — symptoms and causes. Source

Keep reading

All articles
  • Back-to-School Starts in the Gut

    6 min read

    The back-to-school reset comes down to three things a household can genuinely change: what goes in the lunchbox, when the lights go off, and how gently the first…

  • Wellness That Travels With You

    5 min read

    Travel moves three things at once, your clock, your food and your routine, and your gut notices all three. The good news is that most of what helps…